IOVA Operating Cash Flow (Statement)
Iovance Biotherapeutics Inc · Operating Cash Flow (Statement)
IOVA Operating Cash Flow (Statement)
Latest reported-$264.18Mperiod ending
IOVA Cash from Operations (-$57.30K → -$264.18M)
Annual operating cash flow (statement)
High-resolution chart · PNG
IOVA operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -302,408,000 | |
| -352,977,000 | |
| -361,820,000 | |
| -292,757,000 | |
| -227,941,000 | |
| -205,134,000 | |
| -158,889,000 | |
| -101,249,000 | |
| -78,709,000 | |
| -32,668,000 | |
| -18,381,000 | |
| -8,633,247 | |
| -3,662,192 | |
| -2,241,467 | |
| -6,189,199 | |
| -620,805 | |
| -14,448 | |
| -57,303 |